S.Biomedics Co., Ltd. (KOSDAQ:304360)

S.Biomedics Statistics

Total Valuation

S.Biomedics has a market cap or net worth of KRW 397.87 billion. The enterprise value is 401.14 billion.

Market Cap	397.87B
Enterprise Value	401.14B

Important Dates

The next estimated earnings date is Friday, March 20, 2026.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	n/a

Share Statistics

S.Biomedics has 12.22 million shares outstanding. The number of shares has increased by 3.69% in one year.

Current Share Class	11.95M
Shares Outstanding	12.22M
Shares Change (YoY)	+3.69%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	21.93%
Owned by Institutions (%)	n/a
Float	8.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.45
PB Ratio	29.74
P/TBV Ratio	71.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-41.89
EV / Sales	23.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-52.23

Financial Position

The company has a current ratio of 4.71, with a Debt / Equity ratio of 1.06.

Current Ratio	4.71
Quick Ratio	4.04
Debt / Equity	1.06
Debt / EBITDA	n/a
Debt / FCF	-1.84
Interest Coverage	-8.52

Financial Efficiency

Return on equity (ROE) is -55.51% and return on invested capital (ROIC) is -15.27%.

Return on Equity (ROE)	-55.51%
Return on Assets (ROA)	-11.24%
Return on Invested Capital (ROIC)	-15.27%
Return on Capital Employed (ROCE)	-19.15%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.45
Inventory Turnover	3.43

Taxes

In the past 12 months, S.Biomedics has paid 104.25 million in taxes.

Income Tax	104.25M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.43% in the last 52 weeks. The beta is 1.74, so S.Biomedics's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	+47.43%
50-Day Moving Average	30,382.00
200-Day Moving Average	23,902.90
Relative Strength Index (RSI)	44.98
Average Volume (20 Days)	152,846

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, S.Biomedics had revenue of KRW 16.96 billion and -9.58 billion in losses. Loss per share was -810.50.

Revenue	16.96B
Gross Profit	7.63B
Operating Income	-6.77B
Pretax Income	-8.18B
Net Income	-9.58B
EBITDA	-4.81B
EBIT	-6.77B
Loss Per Share	-810.50

Balance Sheet

The company has 18.43 billion in cash and 14.17 billion in debt, with a net cash position of 4.26 billion or 348.85 per share.

Cash & Cash Equivalents	18.43B
Total Debt	14.17B
Net Cash	4.26B
Net Cash Per Share	348.85
Equity (Book Value)	13.38B
Book Value Per Share	489.38
Working Capital	17.97B

Cash Flow

In the last 12 months, operating cash flow was -6.39 billion and capital expenditures -1.29 billion, giving a free cash flow of -7.68 billion.

Operating Cash Flow	-6.39B
Capital Expenditures	-1.29B
Free Cash Flow	-7.68B
FCF Per Share	-628.36

Margins

Gross margin is 45.00%, with operating and profit margins of -39.92% and -56.45%.

Gross Margin	45.00%
Operating Margin	-39.92%
Pretax Margin	-48.24%
Profit Margin	-56.45%
EBITDA Margin	-28.38%
EBIT Margin	-39.92%
FCF Margin	n/a

Dividends & Yields

S.Biomedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.69%
Shareholder Yield	-3.69%
Earnings Yield	-2.41%
FCF Yield	-1.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

S.Biomedics has an Altman Z-Score of 3.48 and a Piotroski F-Score of 3.

Altman Z-Score	3.48
Piotroski F-Score	3